| Titles listed in order of publication— | |
 |
January/February 1999 |
| Page | Title |
| 1 | Analysis of Gabapentin in Serum and Plasma by Solid-Phase Extraction and Gas Chromatography–Mass Spectrometry for Therapeutic Drug Monitoring |
| 7 | Solid-Phase Microextraction for Cannabinoids Analysis in Hair and Its Possible Application to Other Drugs |
| 11 | Highly Sensitive Quantitation of Methamphetamine by Time-Resolved Fluoroimmunoassay Using a New Europium Chelate as a Label |
| 17 | Urinary Lithium: Distribution Shape, Reference Values, and Evaluation of Exposure by Inductively Coupled Plasma Argon-Emission Spectrometry |
| 24 | Cocaine Metabolite Kinetics in the Newborn |
| 29 | The Urinary Elimination Profiles of Diazepam and Its Metabolites, Nordiazepam, Temazepam, and Oxazepam, in the Equine after a 10-mg Intramuscular Dose |
| 35 | Semiautomated Preparation of 3,5,6-Trichloro-2-Pyridinol in Human Urine Using a Zymate XP Laboratory Robot with Quantitative Determination by Gas Chromatography– Negative-Ion Chemical Ionization Mass Spectrometry |
| 41 | Determination of Pyrolysis Products of Smoked Methamphetamine Mixed with Tobacco by Tandem Mass Spectrometry |
| 46 | Archive of Mass Spectral Data Files on Recordable CD-ROMs and Creation and Maintenance of a Searchable Computerized Database |
| 54 | Solid-Phase Microextraction and GC–ECD of Benzophenones for Detection of Benzodiazepines in Urine |
| 62 | SHORT COMMUNICATION: Identification and Quantitation of Cocaine N-Oxide: A Thermally Labile Metabolite of Cocaine |
| 67 | CASE REPORT: Toxicological Findings in a Fatal Ingestion of Methamphetamine |
| 69 | LETTER TO THE EDITOR: Methamphetamine—A Study of Postmortem Redistribution |
| 71 | LETTER TO THE EDITOR: Rifampicin Cross-Reacts with Opiate Immunoassay |
| 72 | LETTER TO THE EDITOR: Performance of AdultaCheck 4 Test Strips for the Detection of Adulteration at the Point of Collection of Urine Specimens Used for Drugs-of-Abuse Testing |
|
March/April 1999 |
| Page | Title |
| 73 | Screening Procedure for Detection of Dihydropyridine Calcium Channel Blocker Metabolites in Urine as Part of a Systematic Toxicological Analysis Procedure for Acidic Compounds by Gas Chromatography–Mass Spectrometry after Extractive Methylation |
| 81 | A Pilot Study to Determine the Usefulness of the Urinary Excretion of Methadone and its Primary Metabolite (EDDP) as Potential Markers of Compliance in Methadone Detoxification Programs |
| 86 | Determination of Alkylmethylphosphoric Acids, the Main Metabolites of Organophosphorus Nerve Agents, in Biofluids by Gas Chromatography–Mass Spectrometry and Liquid– Liquid-Solid-Phase-Transfer-Catalyzed Pentafluorobenzylation |
| 94 | Fluorimetric Determination of Aluminum Traces in Hemodialysis Solutions Using Mordant Red 19 |
| 99 | Amitriptyline and Procainamide Inhibition of Cocaine and Cocaethylene Degradation in Human Serum In Vitro |
| 103 | Interference in the Quantitation of Methylated Arsenic Species in Human Urine |
| 108 | Determination of Tin, Vanadium, Iron, and Molybdenum in Various Matrices by Atomic Absorption Spectrometry Using a Simultaneous Liquid–Liquid Extraction Procedure |
| 113 | Determination of Salbutamol and Detection of Other b-Agonists in Human Postmortem Whole Blood and Urine by GC–MS-SIM |
| 119 | Accuracy of Five On-Site Immunoassay Drugs-of-Abuse Testing Devices |
| 125 | TECHNICAL NOTE: Oxaprozin Interference with Urinary Benzodiazepine Immunoassays and Noninterference with Receptor Assay |
| 127 | CASE REPORT: Perphenazine Distribution in a Postmortem Case |
| 130 | CASE REPORT: Self-Intoxication with Morphine Obtained from an Infusion Pump |
| 134 | LETTER TO THE EDITOR: A Safer Method for the Measurement of Plasma Thiocyanate |
|
May/June 1999 |
| Page | Title |
| 137 | The Measurement of Nitrite in Adulterated Urine Samples by High-Performance Ion Chromatography |
| 141 | Prevalence of Drugs Used in Cases of Alleged Sexual Assault |
| 147 | Nail Analysis for Drugs of Abuse: Extraction and Determination of Cannabis in Fingernails by RIA and GC–MS |
| 153 | Measurement of Cadmium-Induced Metallothionein in Urine by ELISA and Prevention of Overestimation Due to Polymerization |
| 159 | Melatonin: Aeromedical, Toxicopharmacological, and Analytical Aspects |
| 168 | Detection of 6-Acetylmorphine in Vitreous Humor and Cerebrospinal Fluid—Comparison with Urinary Analysis for Proving Heroin Administration in Opiate Fatalities |
| 173 | Procainamide Inhibition of Human Hepatic Degradation of Cocaine and Cocaethylene In Vitro |
| 177 | GC–MS Confirmation of Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone in Urine |
| 187 | Amphetamine and Fenproporex Levels Following Multidose Administration of Fenproporex |
| 195 | Another Use of Silica Gel and Aqueous Eluent for HPLC Analysis of Clozapine and Desmethylclozapine |
| 200 | Etodolac in Equine Urine and Serum: Determination by High-Performance Liquid Chromatography with Ultraviolet Detection, Confirmation, and Metabolite Identification by Atmospheric Pressure Ionization Mass Spectrometry |
| 210 | Pitfalls When Determining Tissue Distributions of Organophosphorus Chemicals: Sodium Fluoride Accelerates Chemical Degradation |
| 216 | Comparison of Solid-Phase Extraction and Supercritical Fluid Extraction for the Analysis of Morphine in Whole Blood |
| 219 | TECHNICAL NOTE: Analytical Detection and Quantitation of Strychnine in Chemically Fixed Organ Tissues |
| 222 | LETTER TO THE EDITOR: Æ9-Tetrahydrocannabivarin (Æ9-THCV) as a Marker for the Ingestion of Cannabis versus Marinol® |
| 225 | LETTER TO THE EDITOR: First Identification of Prednisone in Human Hair by Liquid Chromatography–Ionspray Mass Spectrometry |
| 227 | LETTER TO THE EDITOR: More Data About the New Psychoactive Drug 2C-B |
|
July/August 1999 |
| Page | Title |
| 229 | EDITORIAL: Quality of Proof |
| 230 | Improved Cleanup and Determination of Dialkyl Phosphates in the Urine of Children Exposed to Organophosphorus Insecticides |
| 237 | The Elimination Profiles of Tenoxicam and Hydroxytenoxicam in Equine Urine and Serum after a 200-mg Oral Dose |
| 242 | The Elimination Profiles of Oxaprozin in Equine Urine and Serum after a 4.8-g Dose |
| 247 | Direct Semiquantitative Screening of Drugs of Abuse in Serum and Whole Blood by Means of CEDIA® DAU Urine Immunoassays |
| 257 | Determination of Monomethylarsonic Acid and Dimethylarsinic Acid in Urine by Liquid Chromatography–Tandem Mass Spectrometry |
| 262 | Comparison of Four Derivatizing Reagents for 6-Acetylmorphine GC–MS Analysis |
| 270 | Determination of Buprenorphine and Norbuprenorphine in Urine and Hair by Gas Chromatography–Mass Spectrometry |
| 280 | Studies on Fentanyl and Related Compounds IV. Chromatographic and Spectrometric Discrimination of Fentanyl and its Derivatives |
| 286 | TECHNICAL NOTE: Automated Extraction for the Analysis of 11-nor-D9-Tetrahydrocannabinol-9-Carboxylic Acid (THCCOOH) in Urine Using a Six-Head Probe Hamilton Microlab 2200 and Gas Chrometography–Mass Spectrometry |
| 290 | CASE REPORT: A Case of Aldicarb Poisoning: A Possible Murder Attempt |
| 294 | CASE REPORT: Toxicological Analysis of Sulpiride in a Lethal Poisoning Case |
| 297 | LETTER TO THE EDITOR: Paroxetine Not to Blame |
| 299 | LETTER TO THE EDITOR: Disopyramide Cross-Reactivity in a Commercial Immunoassay Reagent for Methadone |
|
September 1999 |
| Page | Title |
| 301 | Analysis of Gamma-Hydroxybutyrate (GHB) in Urine by Gas Chromatography–Mass Spectrometry |
| 306 | Quantitative Determination of LSD and a Major Metabolite, 2-Oxo-3-Hydroxy-LSD, in Human Urine by Solid-Phase Extraction and Gas Chromatography–Tandem Mass Spectrometry |
| 313 | Monitoring Cocaine Use in Substance-Abuse-Treatment Patients by Sweat and Urine Testing |
| 323 | Urinary Excretion of 11-nor-9-Carboxy-D9-Tetrahydrocannabinol and Cannabinoids in Frequent and Infrequent Drug Users |
| 333 | Storage of Specimens at 4°C or Addition of Sodium Fluoride (1%) Prevents Formation of Ethanol in Urine Inoculated with Candida albicans |
| 337 | Rapid Screening for Diuretic Doping Agents in Urine by C60-Assisted Laser-Desorption-Ionization-Time-of-Flight Mass Spectrometry |
| 343 | Determination of Opiates and Cocaine in Hair as Trimethylsilyl Derivatives Using Gas Chromatography– Tandem Mass Spectrometry |
| 349 | Are Cannabinoids Detected in Hair After Washing with Cannabio® Shampoo? |
| 352 | Identification of Testosterone and Testosterone Esters in Human Hair |
| 357 | Over-the-Counter Anabolic Steroids 4-Androsten-3,17-dione; 4-Androsten-3b,17b-diol; and 19-nor-4-Androsten-3,17-dione: Excretion Studies in Men |
| 367 | A Previously Unidentified Acepromazine Metabolite in Humans: Implications for the Measurement of Acepromazine in Blood |
| 372 | Detection and Identification of Flunixin After Multiple Intravenous and Intramuscular Doses to Horses |
| 380 | CASE REPORT: Fatal Case of Dichloromethane Poisoning |
| 384 | LETTER TO THE EDITOR: Interference of Gemfibrozil with Roche TesTcup |
|
October 1999 |
| Page | Title |
| 386 | Measurement of Low Breath-Alcohol Concentrations: Laboratory Studies and Field Experience |
| 396 | Drug Testing with Alternative Matrices II. Mechanisms of Cocaine and Codeine Disposition in Hair |
| 409 | A Retrospective Study Buprenorphine and Norbuprenorphine in Human Hair After Multiple Doses |
| 416 | Detection of Nanadrolone, Testosterone, and their Esters in Rat and Human Hair Samples |
| 424 | Physiological Concentrations of DHEA in Human Hair |
| 429 | Highly Sensitive Micro-Plate Enzyme Immunoassay Screening and NCI-GC–MS Confirmation of Flunitrazepam and its Major Metabolite 7-Aminoflunitrazepam in Hair |
| 436 | Immunoassay and GC–MS Procedures for the Analysis of Drugs of Abuse in Meconium |
| 446 | Identification and Analysis of the Major Metabolites of Cocaine in Meconium |
| 452 | Correlation of Saliva Codeine Concentrations with Plasma Concentrations after Oral Codeine Administration |
| 460 | A Rapid Reusable Fiber Optic Biosensor for Quantitating Cocaine Metabolite in Urine |
| 468 | Determination of Morphine, Morphine-3-glucuronide, Morphine-6-glucuronide in Plasma after Intravenous and Intrathecal Morphine Administration Using HPLC with Electrospray Ionization and Tandem Mass Spectrometry |
| 474 | Detection of Lysergic Acid Diethylamide (LSD) in Urine by Gas Chromatography–Ion Trap Mass Spectrometry |
| 479 | Quantitation of Alprazolam and a-Hydroxyalprazolam in Human Plasma Using Liquid Chromatography Electrospray Ionization MS–MS |
| 486 | GC–MS Determination of Flunitrazepam and its Major Metabolite in Whole Blood and Serum |
| 490 | Benzodiazepines in Miami-Dade Country, Florida Driving Under the Influence (DUI) Cases (1995–1998) with Emphasis on Rohypnol®: GC–MS Confirmation, Patterns of Use, Psychomotor Impairment, and Results of Florida Legislation |
| 500 | Detection of Methadone, LAAM, and Their Metabolites by Methadone Immunoassays |
| 506 | Development and Evaluation of an Improved Method for Screening of Amphetamines |
| 511 | Metabolic Production of Amphetamine following Multidose Administration of Clobenorex |
| 518 | Simultaneous Determination of Amphetamine, Methamphetamine, Methylenedioxyamphetamine (MDA), Methylenedioxymethamphetamine (MDMA), and Methylenedioxyethyl-amphetamine (MDEA) Enantiomers by GC–MS |
| 524 | Enantioselective Gas Chromatography–Negative Ion Chemical Ionization Mass Spectrometry for Methylphenidate in Human Plasma |
| 531 | Urinary Excretion Profiles of 11-Nor-9-Carboxy-D9-Tetrahydrocannabinol: A D9-THCCOOH to Creatinine Ratio Study |
| 535 | Long-Term Stability of Abused Drugs and Antiabuse Chemotherapeutical Agents Stored at –20°C |
| 541 | Tissue Distribution of Mirtazapine (Remeron®) in Postmortem Cases |
| 544 | Distribution of Mirtazapine (Remeron®) in Thirteen Postmortem Cases |
| 549 | TECHNICAL NOTE: Experience With a Urine Opiate Screening and Confirmation Cutoff of 2000 ng/mL |
| 552 | CASE REPORT: A Fatality Related to the Veterinary Anesthetic Telazol |
| 556 | CASE REPORT: Distribution of Topiramate in a Medical Examiner’s Case |
| 559 | CASE REPORT: Acute Zolpidem Overdose—Report of Two Cases |
| 563 | LETTER TO THE EDITOR: The Effect of Consumption of Hempen Ale® on Urine Cannabinoid Screens |
|
November/December 1999 |
| Page | Title |
| 565 | Impact of Water-Induced Diuresis on Excretion Profiles of Ethanol, Urinary Creatinine, and Urinary Osmolality |
| 570 | The Role of Alcohol Abuse in the Etiology of Heroin-Related Deaths. Evidence for Pharmacokinetic Interactions Between Heroin and Alcohol |
| 577 | Detection of Stimulants in Hair by Laser Microscopy |
| 581 | Sulfonium Salts as Derivatizing Agents. 3. Quantitation of the Cocaine Metabolites Benzoylecgonine in Urine Using Gas Chromatography with Ion-Pair Extraction/On-Column Alkylation |
| 586 | Determination by 1H NMR Spectroscopy of Paraquat in Urine from Acutely Poisoned Patients. Comparison with Second-Derivative Spectroscopy Method |
| 591 | Simultaneous Determination of Ethylene Glycol and Glycolic Acid in Serum by Gas Chromatography–Mass Spectrometry |
| 598 | On-Line Immunoaffinity Extraction and HPLC Analysis of Flunitrazepam and Its Main Metabolites in Serum |
| 603 | A Gas Chromatography–Mass Spectrometry Method for the Quantitation of Clobenzorex |
| 609 | Methadone Screening of Racehorses |
| 615 | Methadone Conversion to EDDP during GC–MS Analysis of Urine Samples |
| 620 | Determination of Opiates and Cocaine and Its Metabolites in Biological Fluids by High-Performance Liquid Chromatography with Electrospray Tandem Mass Spectrometry |
| 625 | Determination of Germanium in Human Specimens: Comparative Study of Atomic Absorption Spectrometry and Microwave-Induced Plasma Mass Spectrometry |
| 632 | Rapid Extraction of Clenbuterol from Human and Calf Urine Using Empore™ C8 Extraction Disks |
| 636 | LETTER TO THE EDITOR: Forensic Toxicology Laboratory Guidelines |
| 637 | LETTER TO THE EDITOR: Interference of Diphenhydramine with the EMIT II Immunoassay for Propoxyphene |
| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |